Rachelle Crescenzi1, Paula M C Donahue2,3, Helen Mahany1, Sarah K Lants1, Manus J Donahue1,4,5. 1. Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee. 2. Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, Tennessee. 3. Vanderbilt Dayani Center for Health and Wellness, Nashville, Tennessee. 4. Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee. 5. Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
PURPOSE: To quantify chemical exchange saturation transfer contrast in upper extremities of participants with lymphedema before and after standardized lymphatic mobilization therapy using correction procedures for B0 and B1 heterogeneity, and T1 relaxation. METHODS: Females with (n = 12) and without (n = 17) breast cancer treatment-related lymphedema (BCRL) matched for age and body mass index were scanned at 3.0T MRI. B1 efficiency and T1 were calculated in series with chemical exchange saturation transfer in bilateral axilla (B1 amplitude = 2µT, Δω = ±5.5 ppm, slices = 9, spatial resolution = 1.8 × 1.47 × 5.5 mm3 ). B1 dispersion measurements (B1 = 1-3 µT; increment = 0.5 µT) were performed in controls (n = 6 arms in 3 subjects). BCRL participants were scanned pre- and post-manual lymphatic drainage (MLD) therapy. Chemical exchange saturation transfer amide proton transfer (APT) and nuclear Overhauser effect (NOE) metrics corrected for B1 efficiency were calculated, including proton transfer ratio (PTR'), magnetization transfer ratio asymmetry ( M T R asymmetry ' ) , and apparent exchange-dependent relaxation (AREX'). Nonparametric tests were used to evaluate relationships between metrics in BCRL participants pre- versus post-MLD (two-sided P < 0.05 required for significance). RESULTS: B1 dispersion experiments showed nonlinear dependence of Z-values on B1 efficiency in the upper extremities; PTR' showed < 1% mean fractional difference between subject-specific and group-level correction procedures. PTR'APT significantly correlated with T1 (Spearman's rho = 0.57, P < 0.001) and body mass index (Spearman's rho = -0.37, P = 0.029) in controls and with lymphedema stage (Spearman's rho = 0.48, P = 0.017) in BCRL participants. Following MLD therapy, PTR'APT significantly increased in the affected arm of BCRL participants (pre- vs. post-MLD: 0.41 ± 0.05 vs. 0.43 ± 0.03, P = 0.02), consistent with treatment effects from mobilized lymphatic fluid. CONCLUSION: Chemical exchange saturation transfer metrics, following appropriate correction procedures, respond to lymphatic mobilization therapies and may have potential for evaluating treatments in participants with secondary lymphedema.
PURPOSE: To quantify chemical exchange saturation transfer contrast in upper extremities of participants with lymphedema before and after standardized lymphatic mobilization therapy using correction procedures for B0 and B1 heterogeneity, and T1 relaxation. METHODS: Females with (n = 12) and without (n = 17) breast cancer treatment-related lymphedema (BCRL) matched for age and body mass index were scanned at 3.0T MRI. B1 efficiency and T1 were calculated in series with chemical exchange saturation transfer in bilateral axilla (B1 amplitude = 2µT, Δω = ±5.5 ppm, slices = 9, spatial resolution = 1.8 × 1.47 × 5.5 mm3 ). B1 dispersion measurements (B1 = 1-3 µT; increment = 0.5 µT) were performed in controls (n = 6 arms in 3 subjects). BCRL participants were scanned pre- and post-manual lymphatic drainage (MLD) therapy. Chemical exchange saturation transfer amide proton transfer (APT) and nuclear Overhauser effect (NOE) metrics corrected for B1 efficiency were calculated, including proton transfer ratio (PTR'), magnetization transfer ratio asymmetry ( M T R asymmetry ' ) , and apparent exchange-dependent relaxation (AREX'). Nonparametric tests were used to evaluate relationships between metrics in BCRL participants pre- versus post-MLD (two-sided P < 0.05 required for significance). RESULTS:B1 dispersion experiments showed nonlinear dependence of Z-values on B1 efficiency in the upper extremities; PTR' showed < 1% mean fractional difference between subject-specific and group-level correction procedures. PTR'APT significantly correlated with T1 (Spearman's rho = 0.57, P < 0.001) and body mass index (Spearman's rho = -0.37, P = 0.029) in controls and with lymphedema stage (Spearman's rho = 0.48, P = 0.017) in BCRL participants. Following MLD therapy, PTR'APT significantly increased in the affected arm of BCRL participants (pre- vs. post-MLD: 0.41 ± 0.05 vs. 0.43 ± 0.03, P = 0.02), consistent with treatment effects from mobilized lymphatic fluid. CONCLUSION: Chemical exchange saturation transfer metrics, following appropriate correction procedures, respond to lymphatic mobilization therapies and may have potential for evaluating treatments in participants with secondary lymphedema.
Authors: Rachelle Crescenzi; Paula M C Donahue; Katherine G Hartley; Aditi A Desai; Allison O Scott; Vaughn Braxton; Helen Mahany; Sarah K Lants; Manus J Donahue Journal: J Magn Reson Imaging Date: 2017-02-28 Impact factor: 4.813
Authors: Manus J Donahue; Paula C M Donahue; Swati Rane; Christopher R Thompson; Megan K Strother; Allison O Scott; Seth A Smith Journal: Magn Reson Med Date: 2015-03-07 Impact factor: 4.668
Authors: Shu Zhang; Jochen Keupp; Xinzeng Wang; Ivan Dimitrov; Ananth J Madhuranthakam; Robert E Lenkinski; Elena Vinogradov Journal: Magn Reson Med Date: 2017-09-01 Impact factor: 4.668
Authors: Li Zou; Feng-Hua Liu; Pei-Pei Shen; Yan Hu; Xiao-Qian Liu; Ying-Ying Xu; Qi-Liang Pen; Bei Wang; Ya-Qun Zhu; Ye Tian Journal: Breast Cancer Date: 2018-02-03 Impact factor: 4.239
Authors: Lisa M Sedger; Dedreia L Tull; Malcolm J McConville; David P De Souza; Thusitha W T Rupasinghe; Spencer J Williams; Saravanan Dayalan; Daniel Lanzer; Helen Mackie; Thomas C Lam; John Boyages Journal: PLoS One Date: 2016-05-16 Impact factor: 3.240
Authors: Rachelle Crescenzi; Paula M C Donahue; Maria Garza; Chelsea A Lee; Niral J Patel; Victoria Gonzalez; R Sky Jones; Manus J Donahue Journal: Breast Cancer Res Treat Date: 2021-10-23 Impact factor: 4.624
Authors: Paula M C Donahue; Rachelle Crescenzi; Chelsea Lee; Maria Garza; Niral J Patel; Kalen J Petersen; Manus J Donahue Journal: Breast Cancer Res Treat Date: 2020-06-29 Impact factor: 4.872